116 related articles for article (PubMed ID: 9868986)
1. Improving glycaemic control with current therapies.
Birkeland KI
Diabet Med; 1998; 15 Suppl 4():S13-9. PubMed ID: 9868986
[TBL] [Abstract][Full Text] [Related]
2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
4. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
5. Insulin therapy in type 2 diabetes.
Mudaliar S; Edelman SV
Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
[TBL] [Abstract][Full Text] [Related]
6. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
van Raalte DH; Verchere CB
Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.
Porte D
Diabetes Metab Res Rev; 2001; 17(3):181-8. PubMed ID: 11424231
[TBL] [Abstract][Full Text] [Related]
8. Optimising therapy for insulin-treated type 2 diabetes mellitus.
Hermann LS
Drugs Aging; 2000 Oct; 17(4):283-94. PubMed ID: 11087006
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control.
Goddijn PP; Bilo HJ; Feskens EJ; Groeniert KH; van der Zee KI; Meyboom-de Jong B
Diabet Med; 1999 Jan; 16(1):23-30. PubMed ID: 10229289
[TBL] [Abstract][Full Text] [Related]
10. Potential new treatments for type 2 diabetes.
Bailey CJ
Trends Pharmacol Sci; 2000 Jul; 21(7):259-65. PubMed ID: 10871894
[TBL] [Abstract][Full Text] [Related]
11. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
12. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.
Standl E; Füchtenbusch M
Diabetologia; 2003 Mar; 46 Suppl 1():M30-6. PubMed ID: 12652356
[TBL] [Abstract][Full Text] [Related]
13. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
14. Approaches to the management of postprandial hyperglycaemia.
Landgraf R
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S128-32. PubMed ID: 10522837
[TBL] [Abstract][Full Text] [Related]
15. Before oral agents fail: the case for starting insulin early.
Marre M
Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S25-30. PubMed ID: 12174320
[TBL] [Abstract][Full Text] [Related]
16. Management of type 2 diabetes mellitus in the elderly: special considerations.
Rosenstock J
Drugs Aging; 2001; 18(1):31-44. PubMed ID: 11232737
[TBL] [Abstract][Full Text] [Related]
17. New frontiers in the management of type 2 diabetes.
Mudaliar S
Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus.
Galligan A; Greenaway TM
Intern Med J; 2016 May; 46(5):540-9. PubMed ID: 27170238
[TBL] [Abstract][Full Text] [Related]
19. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
[TBL] [Abstract][Full Text] [Related]
20. Repaglinide in combination therapy.
Moses R
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):33-8. PubMed ID: 12702006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
